Literature DB >> 16565226

Potential prognostic value of leptin receptor in hepatocellular carcinoma.

S-N Wang1, S-C Chuang, Y-T Yeh, S-F Yang, C-Y Chai, W-T Chen, K-K Kuo, J-S Chen, K-T Lee.   

Abstract

BACKGROUND: Obesity is associated with several human malignancies, including hepatocellular carcinoma (HCC). This association may result from the deregulated expression of adipokines. AIMS: To explore the potential role and the prognostic value of leptin receptor (Ob-R) in HCC.
METHODS: 66 patients with pathologically confirmed HCC were included in this study. Immunohistochemistry was used to evaluate the expression of Ob-R, microvessel density (MVD) and Ki-67 index in these patients. Eventually, the profiles of Ob-R expression, obtained by a semiquantitative scoring system, were further correlated with Ki-67 expression, intratumour MVD, clinicopathological characteristics and overall survival.
RESULTS: High Ob-R expression was seen in 53% of patients with HCC and was significantly correlated with intratumour MVD (high v low; 59.4 (3.2) v 44.7 (3.7); p = 0.004), but not with Ki-67 expression. In addition, Ob-R expression was inversely correlated with vascular invasion (p = 0.037), but not with other known clinicopathological characteristics. The Kaplan-Meier survival curve showed that high Ob-R expression was associated with a better overall survival (p = 0.027). Meanwhile, multivariate analysis showed that Ob-R expression was a significant determinant for HCC (odds ratio 0.02, 95% confidence interval 0.01 to 0.85; p = 0.041).
CONCLUSION: Ob-R expression may have a potential role in the carcinogenesis of HCC. The positive association of Ob-R expression in the cancerous lesions of HCC with the survival outcome can be explained by its inverse correlation with vascular invasion, and may have prognostic value in HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565226      PMCID: PMC1860536          DOI: 10.1136/jcp.2005.033464

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

Review 1.  Cancer epidemiology in the last century and the next decade.

Authors:  J Peto
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.

Authors:  S Frachon; G Gouysse; J Dumortier; A Couvelard; M Nejjari; F Mion; F Berger; P Paliard; O Boillot; J Y Scoazec
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

Review 3.  Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).

Authors:  David P Rose; Elaine M Gilhooly; Daniel W Nixon
Journal:  Int J Oncol       Date:  2002-12       Impact factor: 5.650

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

5.  Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Authors:  Satheesh Nair; Andrew Mason; James Eason; George Loss; Robert P Perrillo
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

6.  Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Ya-Yu Wang; Shih-Yi Lin
Journal:  Horm Res       Date:  2003

7.  Expression of leptin and leptin receptor isoforms in the human stomach.

Authors:  H Mix; A Widjaja; O Jandl; M Cornberg; A Kaul; M Göke; W Beil; M Kuske; G Brabant; M P Manns; S Wagner
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

8.  Obesity and renal cell cancer--a quantitative review.

Authors:  A Bergström; C C Hsieh; P Lindblad; C M Lu; N R Cook; A Wolk
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

9.  Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer.

Authors:  Makoto Ishikawa; Joji Kitayama; Hirokazu Nagawa
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

10.  Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Qing Lu; Yan-Rong Lu; Jie Zhang; Yan Liu; Wen-Dong Wang
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

View more
  16 in total

Review 1.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

Review 3.  SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE.

Authors:  Luiza Vitelo Andrighetto; Aline Kirjner Poziomyck
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

Review 4.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

5.  Prolactin promotes hepatocellular carcinoma through Janus kinase 2.

Authors:  Yao-Tsung Yeh; King-Teh Lee; Chia-Jung Tsai; Yu-Jie Chen; Shen-Nien Wang
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

Review 6.  Leptin in hepatocellular carcinoma.

Authors:  Shen-Nien Wang; King-Teh Lee; Chen-Guo Ker
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

7.  Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.

Authors:  Nikolaos Stefanou; Vassilis Papanikolaou; Yoichi Furukawa; Yusuke Nakamura; Aspasia Tsezou
Journal:  BMC Cancer       Date:  2010-08-19       Impact factor: 4.430

8.  Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Yi-Ming Tao; Xiang Ding
Journal:  Dig Dis Sci       Date:  2008-07-01       Impact factor: 3.199

9.  Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells.

Authors:  Renxiong Wei; Yaoren Hu; Feibo Dong; Xiaozhen Xu; Airong Hu; Guosheng Gao
Journal:  Immunol Cell Biol       Date:  2015-12-07       Impact factor: 5.126

Review 10.  Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.